nature.com search

Loading Filters

Showing 1–50 of 81 results

Loading Filters

29 July 2016 | Open
Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
- S J Jacobus
- , S V Rajkumar
- , M Weiss
- , A K Stewart
- , E A Stadtmauer
- , N S Callander
- , L M Dreosti
- , M Q Lacy
- & R Fonseca
Blood Cancer Journal 6 , e448–e448

Rights & permissionsfor article Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen . Opens in a new window.
11 April 2016
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
- W I Gonsalves
- , S V Rajkumar
- , M A Gertz
- , A Dispenzieri
- , M Q Lacy
- , F K Buadi
- , D Dingli
- , R S Go
- , N Leung
- , P Kapoor
- , S R Hayman
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , Y L Hwa
- , T V Kourelis
- , R A Kyle
- & S K Kumar
Bone Marrow Transplantation 51 , 1156–1158

Rights & permissionsfor article Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy . Opens in a new window.
26 October 2015
Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation
- S S Kenderian
- , F G Rosado
- , D B Sykes
- , J D Hoyer
- & M Q Lacy
Leukemia 29 , 2414–2416

Rights & permissionsfor article Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation . Opens in a new window.
20 March 2015 | Open
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
- V Roy
- , A K Stewart
- , P L Bergsagel
- , A Dispenzieri
- , K Laumann
- , J Allred
- , M Q Lacy
- , R Fonseca
- , C B Reeder
- , S Kumar
- , C E Rivera
- , M A Gertz
- , F K Buadi
- , S R Hayman
- & S V Rajkumar
Blood Cancer Journal 5 , e294–e294

Rights & permissionsfor article Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation . Opens in a new window.
22 October 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
- T V Kourelis
- , S K Kumar
- , G Srivastava
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , R A Kyle
- & A Dispenzieri
Leukemia 28 , 455–457

Rights & permissionsfor article Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma . Opens in a new window.
28 October 2011
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
- S Sinha
- , M A Gertz
- , M Q Lacy
- , A Dispenzieri
- , S R Hayman
- , F K Buadi
- , D Dingli
- , I N Micallef
- , W J Hogan
- , D A Gastineau
- , S V Rajkumar
- & S K Kumar
Leukemia 26 , 1119–1122

Rights & permissionsfor article Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies . Opens in a new window.
13 October 2008
Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT
- N Leung
- , J M Gloor
- , P G Dean
- , M Q Lacy
- , L F Porrata
- & M D Griffin
Bone Marrow Transplantation 43 , 345–346

Rights & permissionsfor article Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT . Opens in a new window.
Research | 3 May 2010
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization
- H V Naina
- , R K Pruthi
- , D J Inwards
- , D Dingli
- , M R Litzow
- , S M Ansell
- , H J William
- , A Dispenzieri
- , F K Buadi
- , M A Elliott
- , D A Gastineau
- , M A Gertz
- , S R Hayman
- , P B Johnston
- , M Q Lacy
- , I N Micallef
- , L F Porrata
- & S Kumar
Bone Marrow Transplantation 46 , 291–293

Rights & permissionsfor article Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization . Opens in a new window.
14 July 2008
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy
- L J Costa
- , V Rodriguez
- , L F Porrata
- , M Q Lacy
- , M A Elliott
- , M A Gertz
- , D A Gastineau
- & M R Litzow
Bone Marrow Transplantation 42 , 497–498

Rights & permissionsfor article Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy . Opens in a new window.
5 April 2011
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma
- P Kapoor
- , S Kumar
- , S J Mandrekar
- , K M Laumann
- , A Dispenzieri
- , M Q Lacy
- , D Dingli
- , M A Gertz
- , R A Kyle
- , P R Greipp
- , S V Rajkumar
- & T E Witzig
Leukemia 25 , 1195–1197

Rights & permissionsfor article Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma . Opens in a new window.
25 February 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
- K Detweiler Short
- , S V Rajkumar
- , D Larson
- , F Buadi
- , S Hayman
- , A Dispenzieri
- , M Gertz
- , S Kumar
- , J Mikhael
- , V Roy
- , R A Kyle
- & M Q Lacy
Leukemia 25 , 906–908

Rights & permissionsfor article Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma . Opens in a new window.
Amendments and Corrections | 7 September 2011
Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
- P Kapoor
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , M Q Lacy
- , D Dingli
- , J R Mikhael
- , V Roy
- , R A Kyle
- , P R Greipp
- , S Kumar
- & S J Mandrekar
Leukemia 25 , 1523–1524

Rights & permissionsfor article Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis . Opens in a new window.
Research | 13 November 2017
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
- R Chakraborty
- , E Muchtar
- , S K Kumar
- , F K Buadi
- , D Dingli
- , A Dispenzieri
- , S R Hayman
- , W J Hogan
- , P Kapoor
- , M Q Lacy
- , N Leung
- & M A Gertz
Bone Marrow Transplantation 53 , 155–161

Rights & permissionsfor article Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation . Opens in a new window.
Research | 14 August 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
- R Chakraborty
- , E Muchtar
- , S K Kumar
- , F K Buadi
- , D Dingli
- , A Dispenzieri
- , S R Hayman
- , W J Hogan
- , P Kapoor
- , M Q Lacy
- , N Leung
- , R Warsame
- , T Kourelis
- , W Gonsalves
- & M A Gertz
Leukemia 32 , 712–718

Rights & permissionsfor article Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation . Opens in a new window.
Research | 1 September 2017
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
- S Ailawadhi
- , J R Mikhael
- , B R LaPlant
- , K M Laumann
- , S Kumar
- , V Roy
- , D Dingli
- , P L Bergsagel
- , F K Buadi
- , S V Rajkumar
- , R Fonseca
- , M A Gertz
- , P Kapoor
- , T Sher
- , S R Hayman
- , A K Stewart
- , A Dispenzieri
- , R A Kyle
- , W I Gonsalves
- , C B Reeder
- , Y Lin
- , R S Go
- , N Leung
- , T Kourelis
- , J A Lust
- , S J Russell
- , A A Chanan-Khan
- & M Q Lacy
Leukemia 32 , 719–728

Rights & permissionsfor article Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial . Opens in a new window.
Research | 1 September 2017 | Open
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
- M Binder
- , S V Rajkumar
- , R P Ketterling
- , P T Greipp
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S R Hayman
- , Y L Hwa
- , S R Zeldenrust
- , J A Lust
- , S J Russell
- , N Leung
- , P Kapoor
- , R S Go
- , W I Gonsalves
- , R A Kyle
- & S K Kumar
Blood Cancer Journal 7 , e600–e600

Rights & permissionsfor article Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma . Opens in a new window.
Research | 18 September 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
- S Sidana
- , N Tandon
- , A Dispenzieri
- , M A Gertz
- , F K Buadi
- , M Q Lacy
- , D Dingli
- , A L Fonder
- , S R Hayman
- , M A Hobbs
- , W I Gonsalves
- , Y L Hwa
- , P Kapoor
- , R A Kyle
- , N Leung
- , R S Go
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , S V Rajkumar
- & S K Kumar
Leukemia 32 , 729–735

Rights & permissionsfor article Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains . Opens in a new window.
Research | 4 September 2017
A phase 1 trial of ⁹⁰Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
- A Dispenzieri
- , A D'Souza
- , M A Gertz
- , K Laumann
- , G Wiseman
- , M Q Lacy
- , B LaPlant
- , F Buadi
- , S R Hayman
- , S K Kumar
- , D Dingli
- , W J Hogan
- , S M Ansell
- , D A Gastineau
- , D J Inwards
- , I N Micallef
- , L F Porrata
- , P B Johnston
- , M R Litzow
- & T E Witzig
Bone Marrow Transplantation 52 , 1372–1377

Rights & permissionsfor article A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma . Opens in a new window.
Research | 10 April 2017
Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival
- N Tandon
- , E Muchtar
- , S Sidana
- , A Dispenzieri
- , M Q Lacy
- , D Dingli
- , F K Buadi
- , S R Hayman
- , R Chakraborty
- , W J Hogan
- , W Gonsalves
- , R Warsame
- , T V Kourelis
- , N Leung
- , P Kapoor
- , S K Kumar
- & M A Gertz
Bone Marrow Transplantation 52 , 1126–1132

Rights & permissionsfor article Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival . Opens in a new window.
Research | 16 June 2017 | Open
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
- P Ravi
- , S Kumar
- , W Gonsalves
- , F Buadi
- , M Q Lacy
- , R S Go
- , A Dispenzieri
- , P Kapoor
- , J A Lust
- , D Dingli
- , Y Lin
- , S J Russell
- , N Leung
- , M A Gertz
- , R A Kyle
- , P L Bergsagel
- & S V Rajkumar
Blood Cancer Journal 7 , e569–e569

Rights & permissionsfor article Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma . Opens in a new window.
Research | 17 February 2017 | Open
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma
- N Tandon
- , S V Rajkumar
- , B LaPlant
- , A Pettinger
- , M Q Lacy
- , A Dispenzieri
- , F K Buadi
- , M A Gertz
- , S R Hayman
- , N Leung
- , R S Go
- , D Dingli
- , P Kapoor
- , Y Lin
- , Y L Hwa
- , A L Fonder
- , M A Hobbs
- , S R Zeldenrust
- , J A Lust
- , W I Gonsalves
- , S J Russell
- & S K Kumar
Blood Cancer Journal 7 , e528–e528

Rights & permissionsfor article Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma . Opens in a new window.
Research | 27 June 2017
Natural history of t(11;14) multiple myeloma
- A Lakshman
- , M Alhaj Moustafa
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , F K Buadi
- , M Q Lacy
- , D Dingli
- , A L Fonder
- , S R Hayman
- , M A Hobbs
- , W I Gonsalves
- , Y L Hwa
- , P Kapoor
- , N Leung
- , R S Go
- , Y Lin
- , T V Kourelis
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , R A Kyle
- & S K Kumar
Leukemia 32 , 131–138

Rights & permissionsfor article Natural history of t(11;14) multiple myeloma . Opens in a new window.
Research | 25 April 2017
Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
- A Dispenzieri
- , C Tong
- , B LaPlant
- , M Q Lacy
- , K Laumann
- , D Dingli
- , Y Zhou
- , M J Federspiel
- , M A Gertz
- , S Hayman
- , F Buadi
- , M O'Connor
- , V J Lowe
- , K-W Peng
- & S J Russell
Leukemia 31 , 2791–2798

Rights & permissionsfor article Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma . Opens in a new window.
Research | 29 July 2016 | Open
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma
- P Ravi
- , S Kumar
- , J T Larsen
- , W Gonsalves
- , F Buadi
- , M Q Lacy
- , R Go
- , A Dispenzieri
- , P Kapoor
- , J A Lust
- , D Dingli
- , Y Lin
- , S J Russell
- , N Leung
- , M A Gertz
- , R A Kyle
- , P L Bergsagel
- & S V Rajkumar
Blood Cancer Journal 6 , e454–e454

Rights & permissionsfor article Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma . Opens in a new window.
Research | 23 May 2016
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
- N Majithia
- , S V Rajkumar
- , M Q Lacy
- , F K Buadi
- , A Dispenzieri
- , M A Gertz
- , S R Hayman
- , D Dingli
- , P Kapoor
- , L Hwa
- , J A Lust
- , S J Russell
- , R S Go
- , R A Kyle
- & S K Kumar
Leukemia 30 , 2208–2213

Rights & permissionsfor article Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents . Opens in a new window.
Research | 4 July 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or older
- E Muchtar
- , D Dingli
- , S Kumar
- , F K Buadi
- , A Dispenzieri
- , S R Hayman
- , R C Wolf
- , D A Gastineau
- , R Chakraborty
- , W J Hogan
- , N Leung
- , P Kapoor
- , M Q Lacy
- , S V Rajkumar
- & M A Gertz
Bone Marrow Transplantation 51 , 1449–1455

Rights & permissionsfor article Autologous stem cell transplant for multiple myeloma patients 70 years or older . Opens in a new window.
Research | 1 December 2016
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
- E Muchtar
- , A Dispenzieri
- , S K Kumar
- , R P Ketterling
- , D Dingli
- , M Q Lacy
- , F K Buadi
- , S R Hayman
- , P Kapoor
- , N Leung
- , R Chakraborty
- , W Gonsalves
- , R Warsame
- , T V Kourelis
- , S Russell
- , J A Lust
- , Y Lin
- , R S Go
- , S Zeldenrust
- , R A Kyle
- , S V Rajkumar
- & M A Gertz
Leukemia 31 , 1562–1569

Rights & permissionsfor article Interphase fluorescence <i>in situ</i> hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category . Opens in a new window.
Research | 16 December 2016 | Open
Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era
- R Chakraborty
- , E Muchtar
- , S K Kumar
- , D Jevremovic
- , F K Buadi
- , D Dingli
- , A Dispenzieri
- , S R Hayman
- , W J Hogan
- , P Kapoor
- , M Q Lacy
- , N Leung
- & M A Gertz
Blood Cancer Journal 6 , e512–e512

Rights & permissionsfor article Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era . Opens in a new window.
Research | 11 March 2016 | Open
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
- M Binder
- , S V Rajkumar
- , R P Ketterling
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S R Hayman
- , Y L Hwa
- , S R Zeldenrust
- , J A Lust
- , S J Russell
- , N Leung
- , P Kapoor
- , R S Go
- , W I Gonsalves
- , R A Kyle
- & S K Kumar
Blood Cancer Journal 6 , e401–e401

Rights & permissionsfor article Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma . Opens in a new window.
Research | 22 August 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
- R Chakraborty
- , E Muchtar
- , S Kumar
- , F K Buadi
- , D Dingli
- , A Dispenzieri
- , S R Hayman
- , W J Hogan
- , P Kapoor
- , M Q Lacy
- , N Leung
- & M A Gertz
Bone Marrow Transplantation 52 , 34–40

Rights & permissionsfor article The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents . Opens in a new window.
Research | 26 July 2016
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
- W I Gonsalves
- , S V Rajkumar
- , A Dispenzieri
- , D Dingli
- , M M Timm
- , W G Morice
- , M Q Lacy
- , F K Buadi
- , R S Go
- , N Leung
- , P Kapoor
- , S R Hayman
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , L Hwa
- , T V Kourelis
- , R A Kyle
- , M A Gertz
- & S K Kumar
Leukemia 31 , 130–135

Rights & permissionsfor article Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression . Opens in a new window.
Research | 23 May 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
- E Muchtar
- , A Dispenzieri
- , S K Kumar
- , F K Buadi
- , M Q Lacy
- , S Zeldenrust
- , S R Hayman
- , N Leung
- , T V Kourelis
- , W Gonsalves
- , R Chakraborty
- , S Russell
- , D Dingli
- , J A Lust
- , Y Lin
- , P Kapoor
- , R Go
- , R A Kyle
- , S V Rajkumar
- & M A Gertz
Leukemia 31 , 92–99

Rights & permissionsfor article Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival . Opens in a new window.
Research | 20 March 2015 | Open
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
- W I Gonsalves
- , N Leung
- , S V Rajkumar
- , A Dispenzieri
- , M Q Lacy
- , S R Hayman
- , F K Buadi
- , D Dingli
- , P Kapoor
- , R S Go
- , Y Lin
- , S J Russell
- , J A Lust
- , S Zeldenrust
- , R A Kyle
- , M A Gertz
- & S K Kumar
Blood Cancer Journal 5 , e296–e296

Rights & permissionsfor article Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma . Opens in a new window.
Research | 12 May 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
- M Alhaj Moustafa
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , Y L Hwa
- , D Dingli
- , P Kapoor
- , S R Hayman
- , J A Lust
- , R A Kyle
- & S K Kumar
Leukemia 29 , 2033–2038

Rights & permissionsfor article Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy . Opens in a new window.
Research | 1 May 2015 | Open
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
- R Warsame
- , S K Kumar
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , S R Hayman
- , N Leung
- , D Dingli
- , J A Lust
- , R P Ketterling
- , Y Lin
- , S Russell
- , L Hwa
- , P Kapoor
- , R S Go
- , S R Zeldenrust
- , R A Kyle
- , S V Rajkumar
- & A Dispenzieri
Blood Cancer Journal 5 , e310–e310

Rights & permissionsfor article Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death . Opens in a new window.
Research | 16 December 2015
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
- T V Kourelis
- , F K Buadi
- , M A Gertz
- , M Q Lacy
- , S K Kumar
- , P Kapoor
- , R S Go
- , J A Lust
- , S R Hayman
- , V Rajkumar
- , S R Zeldenrust
- , S J Russell
- , D Dingli
- , Y Lin
- , N Leung
- , Y L Hwa
- , W Gonsalves
- , R A Kyle
- & A Dispenzieri
Leukemia 30 , 1079–1085

Rights & permissionsfor article Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment . Opens in a new window.
Research | 21 October 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
- G P Kaufman
- , M A Gertz
- , A Dispenzieri
- , M Q Lacy
- , F K Buadi
- , D Dingli
- , S R Hayman
- , P Kapoor
- , J A Lust
- , S Russell
- , R S Go
- , Y L Hwa
- , R A Kyle
- , S V Rajkumar
- & S K Kumar
Leukemia 30 , 633–639

Rights & permissionsfor article Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma . Opens in a new window.
Research | 23 October 2015 | Open
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy
- B Siontis
- , S Kumar
- , A Dispenzieri
- , M T Drake
- , M Q Lacy
- , F Buadi
- , D Dingli
- , P Kapoor
- , W Gonsalves
- , M A Gertz
- & S V Rajkumar
Blood Cancer Journal 5 , e364–e364

Rights & permissionsfor article Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy . Opens in a new window.
Research | 23 October 2015 | Open
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma
- T Vu
- , W Gonsalves
- , S Kumar
- , A Dispenzieri
- , M Q Lacy
- , F Buadi
- , M A Gertz
- & S V Rajkumar
Blood Cancer Journal 5 , e363–e363

Rights & permissionsfor article Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma . Opens in a new window.
Research | 14 August 2015 | Open
Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib
- S K Kumar
- , B LaPlant
- , V Roy
- , C B Reeder
- , M Q Lacy
- , M A Gertz
- , K Laumann
- , M A Thompson
- , T E Witzig
- , F K Buadi
- , C E Rivera
- , J R Mikhael
- , P L Bergsagel
- , P Kapoor
- , L Hwa
- , R Fonseca
- , A K Stewart
- , A Chanan-Khan
- , S V Rajkumar
- & A Dispenzieri
Blood Cancer Journal 5 , e338–e338

Rights & permissionsfor article Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib . Opens in a new window.
14 August 2015
Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma
- S K Kumar
- , E Ma
- , A E Engebretson
- , F K Buadi
- , M Q Lacy
- , A Dispenzieri
- , M S Duh
- , M-H Lafeuille
- , P Lefebvre
- , W Y Cheng
- , K Dea
- , D Rembert
- , D Patt
- , L Niculescu
- , M Quick
- & S V Rajkumar
Leukemia 30 , 995–998

Rights & permissionsfor article Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma . Opens in a new window.
Research | 25 October 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- S K Kumar
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S Pandey
- , P Kapoor
- , D Dingli
- , S R Hayman
- , N Leung
- , J Lust
- , A McCurdy
- , S J Russell
- , S R Zeldenrust
- , R A Kyle
- & S V Rajkumar
Leukemia 28 , 1122–1128

Rights & permissionsfor article Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients . Opens in a new window.
Research | 24 September 2012
Second auto-SCT for treatment of relapsed multiple myeloma
- W I Gonsalves
- , M A Gertz
- , M Q Lacy
- , A Dispenzieri
- , S R Hayman
- , F K Buadi
- , D Dingli
- , W J Hogan
- & S K Kumar
Bone Marrow Transplantation 48 , 568–573

Rights & permissionsfor article Second auto-SCT for treatment of relapsed multiple myeloma . Opens in a new window.
Research | 4 November 2013
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy
- S K Kumar
- , J Mikhael
- , B LaPlant
- , M Q Lacy
- , F K Buadi
- , D Dingli
- , M A Gertz
- , K Laumann
- , T Miceli
- , M Mahlman
- , L P Bergsagel
- , S R Hayman
- , C Reeder
- , A K Stewart
- , A Dispenzieri
- , D A Gastineau
- & J L Winters
Bone Marrow Transplantation 49 , 201–205

Rights & permissionsfor article Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy . Opens in a new window.
Research | 10 September 2012
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
- M A Gertz
- , M Q Lacy
- , A Dispenzieri
- , S K Kumar
- , D Dingli
- , N Leung
- , W J Hogan
- , F K Buadi
- & S R Hayman
Bone Marrow Transplantation 48 , 557–561

Rights & permissionsfor article Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis . Opens in a new window.
Research | 7 May 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
- G Srivastava
- , V Rana
- , M Q Lacy
- , F K Buadi
- , S R Hayman
- , A Dispenzieri
- , M A Gertz
- , D Dingli
- , S Zeldenrust
- , S Russell
- , A McCurdy
- , P Kapoor
- , R Kyle
- , S V Rajkumar
- & S Kumar
Leukemia 27 , 2062–2066

Rights & permissionsfor article Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma . Opens in a new window.
Research | 20 August 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
- T E Witzig
- , K M Laumann
- , M Q Lacy
- , S R Hayman
- , A Dispenzieri
- , S Kumar
- , C B Reeder
- , V Roy
- , J A Lust
- , M A Gertz
- , P R Greipp
- , H Hassoun
- , S J Mandrekar
- & S V Rajkumar
Leukemia 27 , 220–225

Rights & permissionsfor article A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma . Opens in a new window.
Research | 12 March 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
- W I Gonsalves
- , S V Rajkumar
- , V Gupta
- , W G Morice
- , M M Timm
- , P P Singh
- , A Dispenzieri
- , F K Buadi
- , M Q Lacy
- , P Kapoor
- , M A Gertz
- & S K Kumar
Leukemia 28 , 2060–2065

Rights & permissionsfor article Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma . Opens in a new window.
Research | 22 April 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
- A Dispenzieri
- , K Seenithamby
- , M Q Lacy
- , S K Kumar
- , F K Buadi
- , S R Hayman
- , D Dingli
- , M R Litzow
- , D A Gastineau
- , D J Inwards
- , I N Micallef
- , S M Ansell
- , P B Johnston
- , L F Porrata
- , M M Patnaik
- , W J Hogan
- & M A A Gertz
Bone Marrow Transplantation 48 , 1302–1307

Rights & permissionsfor article Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center. . Opens in a new window.
Research | 9 September 2010
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
- M Q Lacy
- , S R Hayman
- , M A Gertz
- , K D Short
- , A Dispenzieri
- , S Kumar
- , P R Greipp
- , J A Lust
- , S J Russell
- , D Dingli
- , S Zeldenrust
- , R Fonseca
- , P L Bergsagel
- , V Roy
- , J R Mikhael
- , A K Stewart
- , K Laumann
- , J B Allred
- , S J Mandrekar
- , S V Rajkumar
- & F Buadi
Leukemia 24 , 1934–1939

Rights & permissionsfor article Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM) . Opens in a new window.